Summary: A rapid and sensitive high perfbrmance liquid Chromatographie method was developed for Separation and quantitation of acetaminophen, salicylic acid and salieyluric acid in human plasma and urine. The method involved ethyl acetate extraction of the three drugs from plasma or urine followed by evaporation of the organic solvent phase and dissolution of the residue in 100 methanol. A 20 aliquot was analysed on a reversed phase column using an isocratic System of 60 ml/l acetonitrile in 4 mmol/1 phosphate buffer, pH 5.7 äs a mobile phase and a variable wave length UV detector se\ at 237 nm. The procedure was used to determine the amounts of the three compounds in plasma and urine of two healthy volunteers who ingested 650 mg of aspfrin® followed one hour later by 650 mg of acetaminophen.
n ro uc on
We hypothise that co-administration of acetaminophen Acetaminophen and salicylates are the most common and salicylates, especially for prolonged periods, may drugs used äs analgesics and antipyretics. Although these cause competitive Inhibition of ghicurpnidation of are supposed to be given ängly, thefe are many cpmacetaminophen. Saturation of this pathway may result mercial prpducts available which contain bpth in a in shunting to other pathways with formation of toxic single dpsage form. In order to achieve a rapid therapeumetabolites of acetaminophen which may lead to hepatotic effeet without the risk of chronic sälicylism, physicellular death (3) . cians preseribe these drugs in a eömbined, alternate ^^ ^ hazard from combination of both drugs dosage regimen.
prömpted us to develpp a simple and rapid method for Alteration of the mode of biotransformation of acetSeparation and quantitation of both drugs and their ammpphen by other drugs has been weU documented.
metabolites in biological fluids. Houston & Levy (1) dempnstrated that ascorbic acid, admintetered in conjunction with acetaminophen, A number of spectrophotometric (5-7) methods used agnificantly reduces the excretion rate of acetaminofor detection and quantitation of these drugs, can detect phen sulfate. Levy et al. (2) (8, 9) , and salicylates a ) Fellow from the Pediatnc Department, Tanta ümversity, / r ·*· j · · u Tarita, Egypt. -Research supported by the Agency for Inter- (10, 11) . These methods are sensitive and specific, hownational Development, U^.A. ever, chemical derivatisation is necessary. Hence, they are time consuniing and require high technical experience. High performance liquid Chromatographie methods (12) (13) (14) were used for determination of acetaminophen alone. Other HPLC methods (15) (16) (17) (18) (19) were used for determination of salicylic acid and/or salicyluric acid. There is only one HPLC method (20) that determined both acetaminophen and salicylic acid simultaneöüsly. However, the close and short retention times of acetaminophen and salicylic acid (2.15 and 2.90 min respectively) prevented the complete Separation of both compounds from each other and from other biological compounds.
We describe in this report a reliable method for simultaneous quantitative determination of acetaminophen, salicylic acid and salicyluric acid in pläsma or urine using HPLC. Analytical.procedures Extraction 100 of pläsma or urine was diluted to 1.0 ml with distilled water after adjusting pH of pläsma to 2.0 and pH of urine to 5.0. Fifteen ml of ethyl acetate and 4 g sodium Chloride were added to the pläsma or urine in 40 ml volume glass tube with a glass stopper. The tube was shaken vigorously on a shaking apparatus for 15 min then centrifuged for 10 min to separate the phases. Ten ml of the ethyl acetate phase were aspirated into a clean tube. The ethyl acetate was evaporated to dryriess at 45 ° C under a gentle stream of nitrogen. The residue was dissolved in 100 methanol and mixed thoroughiy usiiig a vortex. A 20 aliquot was injected into the liquid Chromatograph.
Materials and Methods

Apparatus
HPLCanalysis
After several trials, optimal Separation of the three compounds was accomplished by eluting with 60 ml/l acetonitrile in 4 mmol/1 Phosphate buffer, pH 5.7. The flow rate was set at l ml/min. The module chart speed was l cm/min.. Absorbance was monitored at 237 nrn and recorded on the data module. Quantitäten of peak areas using external Standard technique was carried out using the data module Integrator. Internal Standard was found unnecessary, because by repeated injectipns of the three compounds into HPLC, reproducible resuits to within 4% were constantly achieved, besides the simplicity and complete recovery of the extraction procedure. ' Urinary excretion of free acetaminophen, salicylic äcid and salicyluric acid in man Two healthy volunteers, 26 and 33 years old and weighirig 163 and 136 pounds (ca. 74 and ca. 62 kg) and with no histpry of drug intake in the twelve week period preceding the test were studied. Each volunteer was given an oral döse pf 650 mg Pf äspirin® after an overnight fast. One hour later, each subject was given 650 mg of acetaminophejn. No food was allowed up to t wo hours äfter acetamiriPphen intake. Both volunteers were allowed to drink water and fruit Juices to increase urine flow. Ürine samples were collected from äspirin® admifiistfatipri every l to 2 hours up to 12 hours, and at 24 hours. Urine samples were filtered and pH and volume of each sample were deterr mined. The samples were stored at -30 ° C up till the time of analysis.
Plasma concentration of free acetaminophen, salicylic acid and salicyluric acid in man Blood samples were taken every 15 min to l hour up to four hours following drug administration. Each blood sample was receiVed in a heparinized test tube and centrifuged. Plasma was aspirated and stored at -30 ° C up till the time of analysis.
Resuits and Discussion
The objective of this report is to develop a simple and sensitive HPLC method for simultaneous Separation and quantitation of acetaminophen, salicylic acid and its main metabolite salicyluric acid in biological fluids. Also, to evaluate previoüsly reported methodology for these compounds (10, (12) (13) (14) (15) (16) (17) (18) (19) . The method ofMiceli et al. (20) , which was carried out only on pläsma for simultaneous measurement of acetaminophen and salicylic acid lacks the complete Separation öf both compounds due to their close retention times (2.15 and 2.90 min). The short retention times of both compounds prevent their cleär Separation from the biological background when this procedure is applied to urine samples. In addition, this method did not describe salicyluric acid determination. The method deyelbped in our laboratory is simple, sensitive and cän be applied for determination of both compounds and their metJl·· bölites in serum or üfirie in subtherapeutic, therapeutic or toxic doses of each or both drugs. ;; Optimization of extraction efficiency Extraction solvent Several solvents have been used for extraction of acetaminophen, salicylic acid and salicyluric acid. Levy & Yamada (2) and others (12,13) used diethyl ether for extraction of acetaminophen from plasma and urine while Rowland & Riegelman (10) used the same solvent for extraction of salicylic acid from plasma. Levy & Procknal (21) used ethylene dichloride for extraction of both salicylic acid and salicyluric acid from urine samples. Miceli et al. (20) used a solvent mixture of Chloroform and isopropanol l/l by volume for extraction of both acetaminophen and salicylic acid from serum. In an attempt to develop one method of extraction of the three compounds from plasma and urine simultaneously, we tried these solvents in addition to ethyl acetate. Data in table l show the extraction efficiency of these solvents to 10 mg/1 of each of acetaminophen, salicylic acid and salicyluric acid added to drug-free plasma and urine. The same extraction procedure was applied.for alPsolvent Systems used.
From plasma the extraction efficiency of ether for acetaminophen and salicyluric acid was found to be high, however, for salicylic acid it was low. This indicates that ether is not a gopd extraction solvent for salicylic acid contrary to an earlier report (10) . Ethylene dichloride has a very low extraction efficiency for acetaminophen and it was found that its capäbility for extraction of both salicylic acid and salicyluric acid lies within 50--55% f This may seem contradictory to the previously reported methods considering ethylene dichloride äs an efficient extractor for these compounds. This can be explaihed by the difference in pH of the biological medium during extraction. Ethylene dichloride was used previously äs an extraction solvent at very low pH (21) which allows more efficient extraction for salicylic acid and salicyluric acid. This low pH may be suitable for specirophotometric methods but we observed in our HPLC analysis that at this low pH other compounds were extracted äiid inteirfered with the compounds under study. The extraction efficiency of ethyl acetate from plasma at pH 2 was found to be high for the three compounds without interference by any of the biological compounds. Chloroform/isopropanol, l/l by volume has a high extraction efficiency for acetaminophen, niode rate for salicylic acid and low for salicyluric acid at this pH (tab. 1).
Frpm urine ether can extract acetaminophen with a high efficiency at pH 5 but it has a low extraction efficiency for salicylic acid at this pH. Ethylene dichloride has a low extraction efficiency at pH 5 for the three compounds. Ethyl acetate was found to have the highest extraction efficiency for these three compounds. Extraction from urine at pH 5 was found unreliable for chloroform/isopropanol mixture due to interference by other compounds extracted with the test compounds. As shown in table l, the extraction efficiency of ethyl acetate for the three compounds from plasma at pH 2 ranges from 98 to 104%. Recovery of acetaminophen, salicylic acid and salicyluric acid from urine at pH 5 was 98%, 87% and 87% respectively. %
Effect ofpH of the biological medium
The pH of the biological medium affects to a great extent the solventes extraction efficiency for these compounds. Our study indicates that salicylic acid and salicyluric acid are better extracted at a more acidic pH. This is due to the minimum ionization of salicylic acid at a pH below its pK a (3.0). Acetaminophen extraction was found not to be greatly affected by changes in pH. Data in table 2 show the extraction efficiency of ethyl acetate for the three compounds at pH 2 and pH 5. As shown the three compounds are completely extracted from plasma at pH 2. Extraction at this pH can only be applied to plasma due to no interference from biological bäckground. However, in urine, äs shown in figure l, extraction at pH 2 is unreliable due to the interference by other compounds simultaneously extracted along with these compounds. Repeated extractions of known concentrations of the three compounds added to drugTab. 1. Extraction efficiency (recovery, %, ± s) of various solvent Systems for acetaminophen, salicylic acid and salicyluric acid from plasma (extraction at pH 2)) and urine (extraction at pÖ 5). * vaiues obtained are unreliable due to interference by biological bäckground. ** less than 1% recovery. free urine at different pH indicated that at pH 5 extraction efficiency ranged from 87 to 98% for all compounds studied. Minimal interference by other biological materials was observed at this pH. Interestingly,Mce// et al. reported (20) that they extracted acetaminophen and salicylic acid at plasma pH (7.4). At that pH salicylic acid is highly ionized and hence very weakly soluble in organic solvents.
Optimization of the HPLC System condition
Effect of mobil&phase
Different mobile phases have been reported for the Separation and quantitation of these compounds ind ividually or in combination. When we tried one of these mobile phases äs (methanol 9 g/l acetic acid; fractions 0.12/0.88) (22), a constant peak was observed having the same retention time äs acetaminophen in the blank biological samples. Hence, it interfered with acetaminophen determination. Under this condition, salicylic acid and salicyluric acid have long retention times (tab. 3). Using other mobile phases resulted in short retention times for all compounds and overlapping by biological background. For these reasons we tried to find a new mobile phase that could clearly separate these com ? pounds without interference from other biological background. We found that 60 ml/1 acetonitrile in 4 mmol/1 phosphate buffer is an ideal mobile phase for this study. Data in table 3 illustrate different mobile phases used and the corresponding retention times of the three compounds studied.
Effect ofpH of mobile phase
The retention time was found to be affected to a great extent by the change in pH of mobile phase. It was observed that the lower the pH the longer the retention times of the three compounds studied. Increasing the pH resulted in short retention times. Data in table 4 indicate that pH 5.7 is optimal for Separation of the three compounds. Slight alteration such äs decimal increase or decrease in the pH was found to alter the retention times. Alteration of pH not only affects the retention time but also chalnges the time intervals between the individual compounds. Therefore Separation is affected. 
Effect of UVdetector waive length
The previpus HPLC Systems used different wave lengths for monitoring acetaminophen, salicylic acid or salicyluric acid. A wave length of 300 nm was used (14, 19) for monitoring salicylic acid. Wave lengths ranging from 247 nm to 254 nm were used (12, 13, 20, 22) for monitoring acetaminophen ör salicylic acid or footh. A wave length 237 nm was used (16),fgr monitoring both salicylic acid and salicylurie acid. In an ättempt to find the UV wave length which provided maximum sensitivity for these compounds, we compared the absorbäiice of each compound separately and in combination with the other twp compounds at various wave lengths. The data in table 5 indicate that 237 nm is the most suitable wave length for monitoring the three compounds simultaneously. For acetaminophen the highest absorbance was observed at wave lengths 237 nm and 250 nm, whlle the highest absorbances for salicylic acid and salicyluric acid were observed at 237 nm. Hence, those previous methods which monitored these last two compounds at wave lengths other than 237 nm lacked the maximum sensitivity and probably underestimated these compounds especially at low concentrations.
The retention times for salicylic acid, salicyluric acid and acetaminophen were 5.7, 7.4 and 9.7 min respec-· tively. Figure 2a shows a chromatogram of a human plasrna blank at pH 2 after extraction by ethyl acetate. Figure 2b shows a chromatogram of a human plasma blank spiked with 10 g each of acetaminophen, salicylic acid and salicyluric acid and extracted äs described before. Figure 2c shows a chromatogram of a human plasma sample 1.5 h after 650 mg of aspirin and 0.5 h after the same dose for acetaminophen. Figure 3a shows a chromatogram of a human urine blank extracted at pH 5. Figure 3b illustrates the same Standards added to drug-free urine and extracted. Figure 3c shows a chromatogram of a human urine sample 2 h after 650 mg each of aspirin and acetaminophen. As shown, chromatograms from blank plasma yielded an extraneous peak aro nd 3.5 min, while chromatograms from blank urine produce peaks between 3.5 and 4.7 min. None of these peaks showed any interference with the three compounds under study. Accuracy and precision of this method for acetaminophen, salicylic acid and salicyluric acid in human plasma and urine are shown in tables 6 and 7. The three compounds were added to drug-free plasma and urine in concentrations ranging from 5 to 50 mg/1 each and extracted s described before. The Standard curves show a linear relationship between the cpncentrations and peak areas over these ranges. The Coefficient of Variation of these results is less than 4% in all concentrations studied. Cpncentratioris lower or higher than this r nge can be estimated with the same efficiency by changing the sample or methanol volumes or by changing the UV detector sensitivity. This method was used to study the urinary excretion in 24 h of free acetaminophen, salicyiic acid and salicyluric acid in two healthy human volunteers who ingested 650 mg of aspirin® followed l h later by 650 mg of acetaminophen. Figure 4 illustrates the excretion of the three compounds in g/l at various times. As shown, acetaminophen concentration in urine was at its highest level 1-2 hours after drug administration. Salicyiic acid and salicyluric acid reached their highest concentration level within 3 to 4 hours following drug administration. From this study we observed that the amount of free acetaminophen excreted in 24 hours accounts for 3.6 to 4.5% of acetaminophen dose. Salicyiic acid accounts for 6.2 to 9.5% of the aspirin® dose while salicyluric acid excretion accounts for 59 to 60% of the aspirin® dose. These figures agree with other reports (5, 23) . This method was also used to study the plasma concentrations of the three compounds for the same volunteers who ingested the previous doses of both aspirin B and acetaminophen. Blood samples were collected every 15 min to l hour up to 4 hours following drug administration. Figure 5 illustrates the plasma concentration versus time of each compound. As shown, the highest plasma concentration of acetaminophen which is 11 mg/1 was obtained 0.5 hour after drug administration. Salicyiic acid and salicyluric acid have their highest plasma concentrations (35 mg/1 and 2.8 mg/1 respectively) about 1.5 hour after oral aspirin® administration. The plasma concentrations of the three compounds over 4 hours in our study are in agreement with results presented by Levy et al. (24) . In summary, this HPLC method is simple and reliable for determination and quantitation of acetaminophen, salicylic acid and salicyluric acid in biological fluids. This method is highly sensitive and can detect and quantitate each of the three compounds in a concentration up to l mg/1. The three compounds can be extracted by one solvent and separated during one run in HPLC. A single run lasts only for 15 minutes. This method can also be used for determination of other salicylates and acetaminophen metabolites after acid or enzymatic hydrolysis of these conjugates to the free compound (2, 21) . We are currently using this method for pharmac kinetic and pharmacodynamic studies of a combination of acetaminophen and salicylates in human.
